Nanoscope Technologies was recently awarded an Audacious Goal Initiative (AGI) R01 Grant from the National Eye Insitute (NEI) for a laser gene delivery technology for helping to restore vision in patients with Retinitis Pigmentosa (RP) and other genetic retinal diseases who have lost their photoreceptors.
Scientists at Nanoscope has reportedly developed a highly photosensitive Multi-Characteristics Opsin (MCO) that allows stimulation of retinal cells, leading to restored vision. Through the grant, Nanoscope will reportedly re-sensitize the photo-degenerated retinal areas with MCO by targeted gene delivery using an infrared (IR) ultrafast laser.
Click here to read the full press release.
Source: Nanoscope Technologies